Results 131 to 140 of about 5,791,370 (216)
Invasive Meningococcal Disease. Cuba, 1983- 2006
Invasive Meningococcal Disease (IMD) is a worldwide health problem. In Cuba, vaccination against meningococcal B-C has been carried out since 1989. The study aimed at describing the epidemiology of IMD in Cuba from 1983 to 2006 and at contributing to the
Antonio E. Pérez +2 more
doaj
Meningoccocal meningitis complicated with subdural effusion: a report of two infant cases
Neisseria meningitidis is a major cause of invasive bacterial infection in children of all ages. Children less than 1 year of age are at greater risk of invasive disease than older children. In endemic countries, the invasive meningococcal infections are
Victor Perez-Pico,1 Eduardo Llausas-Magana,1 Angel Leon-Ramirez,1 Giordano Perez-Gaxiola,2 and Nidia Leon-Sicairos.3
doaj
To investigate an outbreak of invasive meningococcal disease (IMD) in Southern ...
Argiolas, Federico +16 more
core +1 more source
Serogroup B Invasive Meningococcal Disease in Older Adults Identified by Genomic Surveillance, England, 2022-2023. [PDF]
We report a cluster of serogroup B invasive meningococcal disease identified via genomic surveillance in older adults in England and describe the public health responses.
Edwards, DS +6 more
core +1 more source
Invasive meningococcal disease in Northland, New Zealand
Invasive meningococcal disease is a serious illness commonly presenting as a meningitis and/or septicaemia. The case fatality rate in New Zealand over the last decade has varied from 4 to 10%, with higher rates for group C ...
Mills, Clair
core
Invasive meningococcal disease presenting as Henoch-Schonlein purpura
Henoch-Schonlein purpura (HSP) is an acute systemic form of vasculitis that has been associated with a number of viral and bacterial infections. Described here are the cases of two children with invasive meningococcal disease who presented with clinical ...
Constantopoulos, A +6 more
core
Patients receiving Eculizumab (Soliris\uae) at high risk for invasive meningococcal disease despite vaccination [PDF]
July 7, 2017, 11:00 ET (11:00 AM ET)CDCHAN-00404Summary: Eculizumab (Soliris\uae) recipients have a 1,000 to 2,000-fold greater risk of invasive meningococcal disease compared to the general U.S. population.
core
Guidelines for meningococcal meningitis/septicaemia chemoprophylaxis
Meningococcal disease is a rare, but serious bacterial infection caused by Neisseria meningitidis. Invasive infection can result in meningitis, septicaemia and sometimes death. With prompt diagnosis, appropriate treatment and supportive measures the case
core
Increase in Invasive Serogroup Y Meningococcal Disease in the United States [PDF]
Distributed via the CDC Health Alert NetworkMarch 28, 2024, 1:30 PM ETCDCHAN-00505The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to alert healthcare providers to an increase in invasive ...
core
Invasive meningococcal disease without meningitis: a forgotten diagnosis
Saqib Walayat,1 Nooreen Hussain,1 Abdullah H Malik,1 Elsa Vazquez-Melendez,1 Bhagat S Aulakh,2 Teresa Lynch1 1Department of Internal Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA; 2Department of Pulmonary/Critical Care ...
Walayat S +5 more
core

